MQVTVQSSPN FTQHVREQSL VTDQLSRRLI RTYQLYSRTS GKHVQVLANK RINAMAEDGDPFAKLIVETD TFGSRVRVRG AETGLYICMN KKGKLIAKSN GKGKDCVFTE IVLENNYTAL QNAKYEGWYM AFTRKGRPRK GSKTRQHQRE VHFMKRLPRG HHTTEQSLRF EFLNYPPFTR SLRGSQRTWA PEPR

Predicted MW

22.5 kDa

Biologically Active

Yes

Biological Activity

ED50: 0.915 ng/ml, as determined by its ability to induce proliferation of NR6-R 3T3, corresponding to a specific activity of 1.1x106U/mg.

Purity

>95% as determined by SDS-PAGE.

Product Form

Lyophilized

Concentration

Reconstitution dependent.

Formulation

Lyophilized from a solution containing 0.1% TFA.

Storage

Shipped at ambient temperature. Lyophilized: Short term (3 weeks) store at 25°C. Long term store desiccated below -18°C. Reconstituted: Short term (2-7 days) store at 4°C. Long term store below -18°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.

Synonyms

AIGF, Androgen induced growth factor, Androgen-induced growth factor, FGF 8, FGF-8, FGF-8b, FGF8_HUMAN, Fibroblast growth factor 8, Fibroblast growth factor 8 (androgen induced), Fibroblast growth factor 8 precursor, HBGF 8, HBGF-8, HBGF8, Heparin-binding growth factor 8, HH6, KAL6

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Publishing research using Recombinant Human FGF8 Protein (A63359)? Please let us know so that we can list the citation on this page.